Eagle Pharmaceuticals Inc (EGRX)

Eagle Pharmaceuticals Inc (EGRX) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.3M; returns 1 day +0.0%, 1 week +13.0%.

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes innovative medicines, particularly injectable formulations, in the areas of critical care, oncology, and rare diseases. They utilize the FDA's 505(b)(2) pathway to efficiently develop improved formulations of branded reference drugs.

Groups EGRX belongs to

• Pharmaceuticals
• Healthcare
• Specialty Chemicals
• 505(b)(2) Pathway
• Biotechnology
• Commercial Stage
• Oncology
• Rare Diseases
• Hematologic Malignancies
• Long-Acting Injectables
• Life Sciences

EGRX financial model: income statement, cash flow and balance sheet